TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Farmastat Norsk Legemiddelstatistikk AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
14,329
|
14,492
|
15,638 |
Financial expenses |
80
|
54
|
10 |
Earnings before taxes |
-316
|
23
|
634 |
Total assets |
7,530
|
8,758
|
10,125 |
Current assets |
4,525
|
5,661
|
6,157 |
Current liabilities |
2,259
|
2,778
|
3,755 |
Equity capital |
5,154
|
5,777
|
6,074 |
- share capital |
1,326
|
1,413
|
1,491 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.4%
|
66.0%
|
60.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
-2.2%
|
0.2%
|
4.1% |
Return on assets (ROA) |
-3.1%
|
0.9%
|
6.4% |
Current ratio |
200.3%
|
203.8%
|
164.0% |
Return on equity (ROE) |
-6.1%
|
0.4%
|
10.4% |
Change turnover |
728
|
-324
|
2,243 |
Change turnover % |
5%
|
-2%
|
17% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.